SLR Solectron Corp

Solectron Corporation (NYSE:SLR), a leading provider of integrated electronic supply chain services including design, manufacturing and aftermarket services, has finalized an agreement with CSA Medical to manufacture the company�s CryoSpray AblationTM system. Following eight years of invention, testing, product development and clinical trials, CSA Medical�s CryoSpray Ablation system is rolling off the assembly line at Solectron�s Charlotte, N.C. manufacturing facility. Based in Baltimore, MD, CSA Medical developed the CryoSpray Ablation system, which freezes and destroys unwanted tissues found in the esophagus, which, according to various reports arises from chronic acid reflux. Peer-reviewed research estimates 65 million U.S. citizens suffer from this condition. The 10 to 20 minute procedure uses a catheter to transport and spray liquid nitrogen under low pressure through an endoscope to freeze the tissue. Solectron's integrated supply chain services and medical manufacturing capabilities enable CSA Medical to accelerate time-to-market without making costly infrastructure investments. In addition to manufacturing the CryoSpray Ablation system, Solectron manages orders and ships directly to CSA Medical customers. CSA Medical and Solectron have worked together since August 2006 to establish an optimized Lean supply chain and manufacturing process. �We needed a contract manufacturing partner with deep medical device expertise, complex systems mastery, and end-to-end manufacturing and supply chain capabilities," said Freddy Cannady, vice president, Operations, CSA Medical. "Solectron met this criterion, and has been, and will continue, to be a valued partner throughout this process.� �CSA Medical�s CryoSpray Ablation System is an innovative approach to treating patients with esophageal diseases, and we�re proud to partner with them to help bring this product to market," said Dave Busch, vice president, medical, Solectron. �Medical device firms are under tremendous pressure to quickly develop high quality products that meet physician and patient needs. Solectron is able to provide customers like CSA Medical with the supply chain expertise and the manufacturing flexibility that their complex products require in a rapidly changing clinical environment.� �Solectron truly lives a Lean Six Sigma culture. This has made it easier to integrate our world-class product with a contract manufacturer that maintains compliance with stringent U.S. and international regulatory requirements, and utilizes highly efficient and precise continuous flow techniques. In my experience, few do this well,� added Cannady. �We needed a contract manufacturer who could provide one-stop support and complete system-level integration. We utilized Solectron�s packaging and testing site in Columbia, S.C. to design our �green� packaging to ensure our product arrives safely anywhere in the world and can be cycled back to manufacturing for continuous reuse.� Safe Harbor This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, but not limited to, the�successful manufacture and distribution of the CryoSpray Ablation system. These forward-looking statements involve a number of risks and uncertainties, and are based on current expectations, forecasts and assumptions. Actual outcomes and results could differ materially. These risks and uncertainties include: unanticipated challenges relating to manufacturing medical products;�supply chain management and logistics issues; product issues�or problems relating to the design of the product; business disruptions; the present and future strength of the worldwide economy overall, and�the market for this medical product in particular; variations in demand forecasts and orders; and our ability to retain key personnel. For a further list and description of risks and uncertainties, see the reports filed by Solectron with the Securities and Exchange Commission. Solectron disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. About CSA Medical CSA Medical, Inc. is committed to bringing the proven science of cryotherapy to Endoscopy. The CSA� System allows therapeutic endoscopists to have the ability to quickly and easily ablate unwanted tissue. The CSA� System utilizes a patented, FDA cleared technology that regulates and transports a low-pressure cryogen through a 7 French catheter that is easily passed through a standard endoscope. This rapid delivery system of repetitive freeze-thaw cycles has been shown in clinical studies to ablate pre-cancerous and cancerous cells with subsequent re-growth of normal esophageal epithelium. CSA Medical is privately held and headquartered in Baltimore, Maryland (www.CSAmedical.com). About Solectron Solectron Corporation is one of the world�s largest providers of complete product lifecycle services. We offer collaborative design and new product introduction, supply chain management, Lean manufacturing and aftermarket services such as product warranty repair and end-of-life support to leading customers worldwide. Solectron works with the world's premier providers of networking, telecommunications, computing, storage, consumer, automotive, industrial, medical, self-service automation and aerospace and defense products. The company's industry-leading Lean Six Sigma methodology (Solectron Production System�) provides OEMs with quality, flexibility, innovation and cost benefits that improve competitive advantage. Based in Milpitas, Calif., Solectron operates in more than 20 countries on five continents and had sales from continuing operations of $10.6 billion in fiscal 2006. For more information, visit us at www.solectron.com. Note: SOLECTRON and the Solectron logo are registered trademarks of Solectron Corporation.�The Solectron Production System, SPS, and Solectron Supply Chain Solutions Suite are also trademarks of Solectron Corporation.�Other names mentioned are trademarks, registered trademarks or service marks of their respective owners.